SCHEMBL6238955

SCHEMBL6238955

COc1cc(OCc2c(F)cccc2Cl)cc(OC)c1C=O

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.47
LMNA P02545 3/20 0.47
ALDH1A1 P00352 3/20 0.46
MAPT P10636 2/20 0.46
TDP1 Q9NUW8 1/20 0.46
KMT2A Q03164 3/20 0.44
MEN1 O00255 2/20 0.44
RAB9A P51151 2/20 0.44
GAA P10253 1/20 0.44
AR P10275 1/20 0.43
NPSR1 Q6W5P4 2/20 0.42
ALOX12 P18054 1/20 0.42
GPBAR1 Q8TDU6 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
KDM4E B2RXH2 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6235662 0.91 ERN1 (0.45) SMN1; SMN2LMNAALDH1A1TDP1KMT2A
SCHEMBL6235089 0.85 ALDH1A1 (0.50) SMN1; SMN2LMNAALDH1A1MAPTTDP1
SCHEMBL6685562 0.79 ALDH1A1 (0.57) SMN1; SMN2LMNAALDH1A1MAPTTDP1
SCHEMBL6702861 0.78 ALDH1A1 (0.49) SMN1; SMN2ALDH1A1MAPTTDP1KMT2A
SCHEMBL2362378 0.76 MAOA (0.58) SMN1; SMN2LMNAALDH1A1MAPTTDP1
SCHEMBL4909005 0.76 SMN1; SMN2 (0.57) SMN1; SMN2ALDH1A1MAPTTDP1KMT2A
SCHEMBL6232024 0.75 AR (0.50) SMN1; SMN2LMNAALDH1A1MAPTTDP1
SCHEMBL6236017 0.74 SMN1; SMN2 (0.46) SMN1; SMN2LMNAMAPTTDP1KMT2A
SCHEMBL6686184 0.74 MAOB (0.50) LMNA
SCHEMBL6254258 0.74 SMN1; SMN2 (0.45) SMN1; SMN2LMNAALDH1A1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005000309-A2 CHEMICAL COMPOUNDS IONIX PHARMACEUTICALS LIMITED (GB) 2005-01-06 WO disclosed
WO-2004087125-A1 AMINO ACID DERIVATIVES AS INHIBITORS OF MAMMALIAN SODIUM CHANNELS IONIX PHARMACEUTICALS LIMITED (GB) 2004-10-14 WO disclosed